Active Pharmaceutical Ingredients

API Name CAS Number Documentation Status
NSAIDS      
Meloxicam – BP/USP 71125-38-7 Open part DMF Commercial
Lornoxicam – INH 70374-39-9 Open part DMF Commercial
Tenoxicam –  BP/USP 59804-37-4 Under Development
Piroxicam – BP/USP 36322-90-4 Tech pack Commercial
Piroxicam-β-Cyclodextrin complex 96684-40-1 / 121696-62-6 Under Development
Pregabalin – INH/USP 148553-50-8 Tech pack Commercial
Respiratory
Bromhexine HCl- IP/BP/USP 611-75-6 Open part DMF Commercial
Salmeterol Xinafoate – EP 94749-08-3 Tech pack Commercial
Ambroxol HCl – BP/USP 23828-92-4 Under Development
Anti-Allergic
Fexofenadine- IP/BP/USP 83799-24-0 Tech pack Commercial
Cetirizine 83881-51-0 Under Development
Anti-Diabetic
Glimepiride – EP/USP 93479-97-1 Tech pack Commercial
Canagliflozin – INH 842133-18-0 Tech pack Commercial
Linagliptin- INH 668270-12-0 Open part DMF Commercial
Sitagliptin -INH 486460-32-6 Under Development
Anti-Ulcer
Sucralfate – USP 54182-58-0 Tech pack Commercial
Ophthalmic
Olopatadine HCl 140462-76-6 Under Development
Excipient (Oleaginous base)
Ethyl Oleate – IP/BP/USP 111-62-6 Tech pack Commercial
Chlorobutanol Hemihydrate 6001-64-5  – Under Development
Nutritional supplement
Iron Sucrose 8047-67-4 Under Development

Note: Products are not offered in countries where they are covered under the patent. However, ultimate responsibility remains of the customer.